India needs stronger regulations to remain leader in generic drugs: WHO expert

World Health Organization (WHO) Chief Scientist Dr Soumya Swaminathan has said that India needs a strong…

No Time for Placebo: The Hindu Editorial on Gambia Deaths and Drugs Regulation in India

India’s apex drug regulator, Central Drugs Standard Control Organization (CDSCO) has Banned Haryana based Maiden Pharmaceuticals…

Nigeria, Liberia flag Maiden syrup after Gambia’s death

New Delhi The head of India’s top pharma export promotion body warned of growing “negativity” over…

Center sets up committee to examine WHO’s details on 66 child deaths in Gambia

New Delhi: The Center has constituted a four-member panel to probe a detailed report shared by…

special | After WHO’s cough syrup alert, Karnataka warns drug makers on glycerin, propylene glycol

After World The Health Organization (WHO) has issued a medical product alert on four India-made cough…

Message in a Bottle on Quality from The Gambia

The death of 66 children, some of whom were under the age of two, in The…

Firm Behind Gambian Child’s Death A Repeat Offender in India | India News – Times of India

New Delhi: Central Drugs Standard Control Organization (CDSCO) has been ready to reassure people that cough…

Cough syrup to be exported only to Gambia, finds drug regulator’s probe

Distributors Organization says drugs that cause death in Gambia are not available in India, assures Central…

Indian company’s cough syrup may be linked to 66 deaths in Gambia: WHO

The World Health Organization (WHO) on Wednesday issued a medical product alert on four cough and…

Maiden Pharmaceuticals Cough Syrup: WHO issues medical product alert on four cough syrups made by Maiden Pharmaceuticals of India. India News – Times of India

Dozens of children died in The Gambia Kidney injuries may be related to a contaminated cough…